SCHEMBL9328851

SCHEMBL9328851

CSCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159813 1.00
SCHEMBL11458578 0.72
Chloromethane SCHEMBL11788599 0.67
Ethane SCHEMBL11566789 0.67
Methylsulfanylmethane SCHEMBL14352912 0.67
Methylsulfanylmethane SCHEMBL29540305 0.62
Methylsulfanylmethane SCHEMBL237052 0.62
Methylsulfanylmethane SCHEMBL2024895 0.62
Methylsulfanylmethane SCHEMBL3444503 0.62
SCHEMBL99501 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H642-H HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1989-06-06 US claimed
EP-0589018-A1 AMINES AS INHIBITORS OF SQUALENE SYNTHASE ZENECA LIMITED (GB) 1994-03-30 EP disclosed
WO-1993020807-A1 AMINES AS INHIBITORS OF SQUALENE SYNTHASE ZENECA LIMITED (GB) 1993-10-28 WO disclosed